Aprea Therapeutics, Inc. (APRE)

Accounts Payable

$935.14K

Quarterly · Period ending: · USD

APRE logo

APRE Accounts Payable

Latest reported$935.14K
APRE Quarterly Accounts Payable ($1.74M → $935.14K)
High-resolution chart · PNG

APRE accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
935,139
2,940,756
713,668
641,322
1,195,838
1,281,651
1,352,240
1,153,880
964,327
1,318,385
1,670,369
862,552
1,131,197
826,027
842,754
1,136,064
3,989,794
1,988,007
1,773,032
2,548,388
2,361,318
3,456,728
4,503,619
4,349,977
5,443,126
3,006,688
2,176,852
3,510,105
2,323,719
1,739,337
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.